Dr. Paul Martin Discusses How the CMAH Gene Deletion in the mdx Mouse Model of Duchenne Muscular Dystrophy Helps Better Mimic the More Severe Aspects of DMD: June 2011

Guest: Paul Martin, PhD, principal investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital

Access an abstract of this month’s featured research article: A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med. 2010 Jul 28;2(42):42ra54.